We’re hosting a fun 5K in Boston on July 14th at the Kidney Cancer Research Summit, but you’re invited to participate wherever you are and however you’d like! You can sign up to raise money as an individual or team, and your hometown event can be as simple or big as you want to make it. Maybe your local event is a neighborhood walk, a solo run, a bike ride, or a community hike. You can Rock the…
Ivy Riano: Tips to advise on how to plan your ASCO annual meeting / ASCO, ASCO Annual Meeting, cancer, Dartmouth-Hitchcock, early career oncologists, Ivy
Ivy Riano: Tips to advise on how to plan your ASCO annual meeting / ASCO, ASCO Annual Meeting, cancer, Dartmouth-Hitchcock, early career oncologists, Ivy
Don’t miss out on an engaging Tweetorial by Florez Lab and Young Lung Cancer Initiative / cancer, Florez Lab, Lung cancer, OncoDaily, Oncology, tweetorial,
Toni Choueiri: The February ASCO Plenary Series are here / ASCO, ASCO Plenary Series, cancer, DREAMM-7, FRUTIGA, gastric/GE junction adenocarcinoma,
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Dr. Nazli Dizman has traveled across the world to pursue her passion for clinical and translational cancer research and further her career as a medical…
KCRS23 is taking place in Boston! Join us as we continue to collaborate, share innovations, and discuss research progress.You can register NOW for the virtual component…
